Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
danqi tablets
- Development stage
- Unknown
- Lead developer
- Yunnan Sunway Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Danqi Tablets is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Yunnan Sunway Pharmaceutical (also known as Yunnan Sainuo Pharmaceutical). The preparation is primarily composed of two key herbal ingredients: *Salvia miltiorrhiza* (Danshen) and *Panax notoginseng* (Sanqi). It is indicated for the treatment of cardiovascular conditions, particularly those characterized by blood stasis, such as chest pain, palpitations, and angina pectoris. The therapeutic action of Danqi Tablets involves promoting blood circulation, removing blood stasis, and alleviating pain. It is an approved oral medication in China, commonly used to improve microcirculation and manage symptoms of coronary heart disease.
- Brand names
- Danqi Tablets丹七片
- Other names
- 丹参三七片Danshen Sanqi TabletsDanqi Pian
02
Targets
LTB4R2 (Leukotriene B4 receptor 2)PTGIS (Prostacyclin synthase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)TYMP (Thymidine phosphorylase)
Beyond the preview
Go deeper on danqi tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on danqi tablets.